FreedomWorks Originals provides you entertainment and education to help you better understand economics, the workings of government, and our insight into the most important debates facing our nation today. Watch and subscribe today!
Famed Chicago School economist Milton Friedman had many strong opinions over the course of his lifetime. Many of those shaped the way we look at the world and the way we look at the economy. However, Friedman also dedicated a good amount of his time to criticizing government health policy, particularly the Food and Drug Administration (FDA).
There has been some recent uproar over a regulation proposed by the Centers for Medicare and Medicaid Services designed to strengthen Medicaid, the government program that provides health insurance coverage for individuals below certain income levels. The regulation has sparked a curious bipartisan backlash from Capitol Hill and from state governments.
WASHINGTON, D.C. -- In response to the closing of the comment period on the Center for Medicare and Medicaid Services’ proposal on organ procurement, Dan Savickas, FreedomWorks Foundation Regulatory Policy Manager, commented:
FreedomWorks Foundation's Regulatory Action Center (RAC) submitted formal comments to the Department of Health and Human Services (HHS) on their proposal regarding organ donation. This rule would create metrics by which organ procurement organizations (OPO) will be guided. As it stands now, there has been enormous amounts of waste, fraud, and abuse in this space and thousands have died as a result.
In today’s politically charged climate, it often seems that politicians aren’t taken seriously unless they spuriously claim that “people will die” if a certain course of action is or is not taken. The rhetoric has been elevated to such a point that only the threat of life or death seems to get the attention of the masses, regardless of whether or not the claim is true. That’s a shame, because an issue has finally come along that does have grave consequences for thousands of Americans.
The FreedomWorks Foundation's Regulatory Action Center (RAC) submitted formal comments to the Center for Medicare Services (CMS) to urge greater oversight of Organ Procurement Organizations (OPO). These OPOs essentially have a government-granted monopoly on organ recovery. However, they routinely waste taxpayer dollars and leave many struggling to receive organs that should have easily been obtained.
Welcome to FreedomWorks Foundation’s seventeenth regulatory review of 2019! Our Regulatory Action Center proudly updates you with our favorite tidbits from the swamp. We want to smash barriers between bureaucracy and the American people by delivering regulatory news straight to FreedomWorks activists. Check back in two weeks for the next edition.
The Centers for Medicare and Medicaid Services announced today that it planned to reduce the budget to promote health plans available on the ObamaCare exchanges from the roughly $100 million spent during the last open enrollment period to $10 million for the upcoming open enrollment period, which is set to begin on November 1 and end on December 15. There will also be a reduction in funding for Navigators, from $62.5 million last year to $36.8 million this year.
Reports continue to come in about the results of implementing ObamaCare. Recently, the Centers for Medicare and Medicaid Services (CMS) of the Department of Health and Human Services (HHS) released a report on the effectuated enrollment, or in other words selected a plan for the first two months of the year and paid their first month’s premium of ObamaCare. The results were admittedly rather surprising as they did not meet the expectations of where the program was supposed to be at this point.